TWST vs VNO · rev $332.8M vs rev $921.3M
Twist Bioscience Corp (TWST) versus VNO (VNO) — a side-by-side from cached financials, not a winner call.
Twist Bioscience Corp (TWST) is a diagnostics & research company listed on NASDAQ.
VNO (VNO) common stock.
Latest reported TWST revenue for 2026-06-30 was $332.8M. Net income was -$109.6M. Revenue was up 55.2% from 2026-03-31 to 2026-06-30. TWST currently screens at market cap $5.16B.
Latest reported VNO revenue for 2026-06-30 was $921.3M. Net income was $24.6M. VNO currently screens at market cap $0.
TWST currently screens at market cap $5.16B. VNO currently screens at market cap $0.
Not investment advice. Open the TWST and VNO stock pages for the full models.
Not investment advice.